Tom C.  Thomas net worth and biography
Tom C. Thomas Insider Alerts

Get notified the next time Tom C. Thomas buys or sells Vincerx Pharma stock. Enter your email address below to get our daily insider buying and selling report.

Tom Thomas Biography and Net Worth

Insider of Vincerx Pharma
Tom Thomas is the General Counsel and Chief Legal Officer of Vincerx.  Before joining Vincerx, Mr Thomas was a partner at Pillsbury Winthrop Shaw Pittman LLP, a leading international law firm with offices in major metropolitan centers around the world.  He has over 30 years of experience representing life science and technology companies at all stages of development, from start-up and emerging companies, to pre-IPO companies, to large public and private companies.  His practice has focused on corporate and securities matters, including corporate governance, debt and equity financings, public and private acquisitions and dispositions, venture capital financings and investments, SPAC transactions, PIPE offerings, joint ventures and strategic alliances, SEC compliance and reporting, executive compensation, and technology transactions.

Mr Thomas received his BBA in Accounting from the University of Iowa, where he graduated summa cum laude, and his JD from the University of Minnesota Law School, where he graduated magna cum laude.

What is Tom C. Thomas' net worth?

The estimated net worth of Tom C. Thomas is at least $30,314.50 as of June 29th, 2021. Mr. Thomas owns 205,522 shares of Vincerx Pharma stock worth more than $30,314 as of January 21st. This net worth evaluation does not reflect any other assets that Mr. Thomas may own. Additionally, Mr. Thomas receives an annual salary of $444,140.00 as Insider at Vincerx Pharma. Learn More about Tom C. Thomas' net worth.

How old is Tom C. Thomas?

Mr. Thomas is currently 64 years old. There are 3 older executives and no younger executives at Vincerx Pharma. Learn More on Tom C. Thomas' age.

What is Tom C. Thomas' salary?

As the Insider of Vincerx Pharma, Inc., Mr. Thomas earns $444,140.00 per year. There are 3 executives that earn more than Mr. Thomas. The highest earning executive at Vincerx Pharma is Dr. Ahmed M. Hamdy M.D., Co-Founder, Chairman & CEO, who commands a salary of $657,540.00 per year. Learn More on Tom C. Thomas' salary.

How do I contact Tom C. Thomas?

The corporate mailing address for Mr. Thomas and other Vincerx Pharma executives is 260 SHERIDAN AVENUE SUITE 400, PALO ALTO CA, 94306. Vincerx Pharma can also be reached via phone at 650-800-6676. Learn More on Tom C. Thomas' contact information.

Has Tom C. Thomas been buying or selling shares of Vincerx Pharma?

Tom C. Thomas has not been actively trading shares of Vincerx Pharma during the past quarter. Most recently, on Wednesday, December 22nd, Tom C. Thomas bought 1,000 shares of Vincerx Pharma stock. The stock was acquired at an average cost of $10.23 per share, with a total value of $10,230.00. Learn More on Tom C. Thomas' trading history.

Who are Vincerx Pharma's active insiders?

Vincerx Pharma's insider roster includes Laura Bushnell (Director), Ahmed Hamdy (CEO), Raquel Izumi (Insider), Andrew McDonald (Director), Alexander Seelenberger (CFO), and Tom Thomas (Insider). Learn More on Vincerx Pharma's active insiders.

Tom C. Thomas Insider Trading History at Vincerx Pharma

See Full Table

Tom C. Thomas Buying and Selling Activity at Vincerx Pharma

This chart shows Tom C Thomas's buying and selling at Vincerx Pharma by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1$0Total Insider BuyingTotal Insider Selling

Vincerx Pharma Company Overview

Vincerx Pharma logo
Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. It is developing enitociclib, a cyclin-dependent kinase-9 inhibitor that is in Phase 1 clinical trials for treating patients with hematologic malignancies; and VIP236, a small molecule drug conjugate that is in Phase 1 clinical trials to treat solid tumors. The company's preclinical stage product candidates include VIP943 and VIP924 for the treatment of hematologic malignancies. Vincerx Pharma, Inc. was founded in 2019 is based in Palo Alto, California.
Read More

Today's Range

Now: $0.15
Low: $0.14
High: $0.15

50 Day Range

MA: $0.22
Low: $0.14
High: $0.33

2 Week Range

Now: $0.15
Low: $0.14
High: $9.37

Volume

2,381,003 shs

Average Volume

3,853,333 shs

Market Capitalization

$4.96 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.48